Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01246583 · ClinicalTrials.gov registry record · Phase 2
CP-690-550 Ointment For Chronic Plaque Psoriasis
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 71
- Enrollment target
NCT01246583 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 71 participants.
The verdict
NCT01246583, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 71 participants
- Enrollment target
Study Summary
The study is being conducted to see whether CP-690,550 ointment has potential as a safe and effective treatment for adult patients with mild to moderate chronic plaque psoriasis.
Interventions
- DRUG CP-690,550 Ointment 1
- DRUG Vehicle 1
- DRUG CP-690,550 Ointment 2
- DRUG Vehicle 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2011-02-16 |
| Est. Completion | 2011-11-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01246583
The ClinicalTrials.gov registry entry for NCT01246583 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which CP-690,550 Ointment 1 is the first listed.
NCT01246583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01246583 about?
NCT01246583 is a clinical study titled "CP-690-550 Ointment For Chronic Plaque Psoriasis". The study is being conducted to see whether CP-690,550 ointment has potential as a safe and effective treatment for adult patients with mild to moderate chronic plaque psoriasis.
What is the current status of trial NCT01246583?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 71 participants. The study started on 2011-02-16. Estimated completion is 2011-11-29.
What interventions are being tested in trial NCT01246583?
The interventions under investigation include: CP-690,550 Ointment 1 (DRUG), Vehicle 1 (DRUG), CP-690,550 Ointment 2 (DRUG), Vehicle 2 (DRUG).
Who is sponsoring clinical trial NCT01246583?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.